Primary Hypercholesterolemia
Conditions
Keywords
hypercholesterolemia; vitamin D; adjuvant therapy
Brief summary
The investigators planned to research the effect of vitamin D supplementation as an adjuvant therapy for patients with hypercholesterolemia.
Detailed description
Vitamin D is primarily generated in the skin, in response to direct absorption of ultraviolet B radiation. Vitamin D can also be obtained through fortified foods and oral supplements. Lipid abnormalities are common in the general population, and are regarded as a modifiable risk factor for cardiovascular disease. Recently low vitamin D status has been shown to be associated with increased risk of developing hyperlipidemia. Statins are normally the first-line therapy for hypercholesterolemia. It is also reported that vitamin D can improve serum lipid levels. However, its effects on hypercholesterolemia patients remain unclear. The investigators planned to determine the efficacy of combination therapy with statins and vitamin D in a cohort of hypercholesterolemia patients. This study may shed light as to whether oral vitamin D supplementation can be an adjunct therapy in hypercholesterolemia patients.
Interventions
2000 IU vitamin D3 tablets were taken daily for 6 months
2000 IU placebo tablets were taken daily for 6 months
Sponsors
Study design
Eligibility
Inclusion criteria
The main inclusion criteria were for hypercholesterolemia patients with the treatment of statins.
Exclusion criteria
The
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| a change in serum total cholesterol level | after 6 months of vitamin D supplementation | The primary end point was a change in serum total cholesterol level after 6 months of vitamin D supplementation. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| a change in serum triglycerides level | after 6 months of vitamin D supplementation | The change in serum triglycerides level was measured after 6 months of vitamin D supplementation. |
| differences in the incidences of treatment-emergent adverse events | after 6 months of vitamin D supplementation | Treatment-emergent adverse events (TEAEs): hypercalcemia, renal insufficiency, constipation |
Countries
China